Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers
Breast Cancer Research2013Vol. 15(6), pp. R112–R112
Citations Over TimeTop 14% of 2013 papers
Hiroko Masuda, Keith Baggerly, Ying Wang, Takayuki Iwamoto, Takae Brewer, Lajos Pusztai, Kazuharu Kai, Takahiro Kogawa, Pascal Finetti, Daniel Birnbaum, Luc Dirix, Wendy A. Woodward, James M. Reuben, Savitri Krishnamurthy, W. Fraser Symmans, Steven Van Laere, François Bertucci, Gabriel N. Hortobágyi, Naoto T. Ueno
Abstract
Our data show that, like TN-non-IBC, TN-IBC is a heterogeneous disease. Although clinical characteristics differ significantly between IBC and non-IBC, no unique IBC-specific TNBC subtypes were identified by mRNA gene-expression profiles of the tumor. Studies are needed to identify the subtle molecular or microenvironmental differences that contribute to the differing clinical behaviors between TN-IBC and TN-non-IBC.
Related Papers
- → Identification of frequent somatic mutations in inflammatory breast cancer(2017)45 cited
- → Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer(2011)34 cited
- → Genomic and Proteomic Pathway Mapping Reveals Signatures of Mesenchymal-Epithelial Plasticity in Inflammatory Breast Cancer(2011)2 cited
- → A comparative study of clinicopathological characteristics and expression of basal markers (CK5/6 & EGFR) in triple negative and non triple negative breast carcinomas in Kashmir valley.(2017)1 cited
- → A comparison of triple negative versus triple positive breast cancers(2011)